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Paraphenylenediamine (PPD) is a common component of hair dyes and black henna 
tattoos and can cause skin sensitization and allergic contact dermatitis (ACD). The cuta-
neous inflammatory reaction associated with ACD is driven by both CD4+ and CD8+ 
T cells. However, the characteristics of such responses with respect to clonal breadth 
and magnitude are poorly defined. In this study, we have characterized the in  vitro 
recall response of peripheral blood T cells prepared from PPD-allergic individuals to a 
PPD–human serum albumin (HSA) conjugate (PPD–HSA). Quantitative high throughput 
sequencing was used to characterize the changes in the repertoire of T cell receptor (TCR) 
α and β genes after exposure to antigen in vitro. The PPD conjugate induced expansion 
of T cells carrying selected TCRs, with around 800 sequences (around 1%) being 8 or 
more times as abundant after culture than before. The expanded sequences showed 
strong skewing of V and J usage, consistent with an antigen-driven clonal expansion. 
The complementarity-determining region 3 sequences of the expanded TCRs could be 
grouped into several families of related amino acid sequence, but the overall diversity of 
the expanded sample was not much less than that of a random sample of the same size. 
The results suggest a model in which PPD–HSA conjugate stimulates a broad diversity 
of TCRs, with a wide range of stimulation strengths, which manifest as different degrees 
of in vitro expansion.
Keywords: allergic contact dermatitis, T cell receptor repertoire, paraphenylenediamine, T cell immunity, skin 
sensitizer
inTrODUcTiOn
Allergic contact dermatitis (ACD) is a T cell-mediated skin disease. It results from the acquisition of 
skin sensitization to chemicals (metal ions and organic chemicals) encountered at skin surfaces (1). 
ACD is the most common manifestation of immunotoxicity in humans and can be caused by a wide 
array of chemicals including nickel (jewelry), fragrances, preservatives, rubber (gloves), dye (hair 
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colorants), adhesives of various kinds, and topical medications, 
including antibiotics. Little is known about what drives variation 
in the human immune response to sensitizing chemicals, and 
consequently a better understanding of the molecular and cellu-
lar events that underlie skin sensitization would help improve the 
safety assessment of the sensitizing properties of new chemicals 
(2), as well as potentially leading to improved therapeutic strate-
gies. Both CD4+ and CD8+ T cells, interacting with dendritic 
cells and keratinocytes (3), have been implicated in ACD, but 
current models suggest CD8+ effector T cells play a major role 
in the elicitation of contact allergic reactions in mice (4, 5) and 
probably also in humans (6). Studies in mouse models of skin 
sensitization have shown that strong skin sensitizers induce an 
oligoclonal T cell response with a high frequency of CD8 effector 
T cells (7). The details of the recognition by T cells of chemical 
allergens are still poorly understood. An exception is the response 
to divalent metal cations such as nickel, which is a common cause 
of ACD. Metal ions have been shown to bind directly to major 
histocompatibility complex (MHC) molecules or to peptide/
MHC complexes, thus creating new antigenic determinants that 
are recognized as foreign by the T cell compartment (8).
As skin-sensitizing chemicals are haptens, and too small to 
trigger immune responses by themselves, it has been proposed 
that the vigor of the immune response elicited by different 
sensitizing chemicals (and thereby their relative potency) might 
correlate with chemical reactivity and their ability to form stable 
associations with proteins or peptides (9–11). Greater chemical 
reactivity has been suggested to translate into a broader range 
of modified peptides, creating a wider range of potential T cell 
epitopes and hence driving a broader and stronger T cell response 
(12). A global analysis of the repertoire of antigen receptors 
expressed on T cells that respond to a skin sensitizer may provide 
further insight into the processes, which drive skin sensitization 
and ACD. In so doing, our aim has been to develop a quantitative, 
mechanistic understanding of how the dose of chemical sensitizer 
exposure relates to the likelihood of inducing skin sensitization in 
humans. It is anticipated that such understanding will inform and 
improve the safety assessment of chemicals (2, 13).
Recent advances in massively parallel high throughput 
sequencing have opened the possibility of global analysis of the 
T cell repertoire, and several protocols have been reported. We 
have developed a robust single-strand DNA ligation protocol, 
which tags each molecule of T cell receptor (TCR) αβ messenger 
RNA in a sample with a unique molecular barcode before PCR 
amplification and sequencing (14). The most important aspect of 
our protocol is that it allows us to collect quantitative repertoire 
data that accurately reflect TCR abundance. Specifically, the 
molecular barcode allows us effectively to correct both for PCR 
bias and for sequencing error at the analysis stage (15). This is 
not currently possible using the commercial DNA-based TCR 
sequencing platforms. We have also developed a suite of software 
tools for the analysis of the TCR data obtained, which can be used 
to process the raw sequence files and assign a unique unambigu-
ous V, J, and complementarity-determining region (CDR)3 to 
each sequence (16).
In the investigations described here we have applied these 
experimental techniques to characterize the in  vitro response 
of T cells from individuals sensitized to paraphenylenediamine 
(PPD), a component of some hair dyes (17) and a strong skin 
sensitizer (18). PPD–human serum albumin (HSA) conjugate is 
shown to induce proliferation of a subset of peripheral blood T 
cells from sensitized individuals. This proliferative response is 
associated with increased abundance of a small proportion of 
TCRs, with a highly skewed V and J gene usage. The repertoire 
of expanded TCRs reflects antigen-driven proliferation of diverse 
sets of sequence-related TCRs.
PaTienTs anD MeThODs
Donor characteristics
Patients were recruited from those attending the Contact 
Dermatitis Investigation Unit at Salford Royal Hospital for diag-
nosis (by epicutaneous patch testing) of contact allergy. Peripheral 
blood samples (20 ml) were drawn from patients (n = 56), diag-
nosed as being sensitized to PPD into lithium heparin-coated col-
lection tubes (Thermo Fisher Scientific) (15 IU/ml). All patients 
were patch-tested to the hospital standard battery and additional 
relevant series and their own products using Finn Chambers® 
on Scanpor®tape. Readings were undertaken at 48 h (day 2) and 
96 h (day 4) according to ICDRG guidelines. Blood samples were 
obtained from patients who were positive to PPD and graded as 
+ (weak; n = 20), ++ (strong; n = 29), and +++ (extreme; n = 7). 
The study was approved by NRES Ethics Committee North West, 
Greater Manchester East (12/NW/0602), and all patients gave 
written informed consent.
Peripheral Blood Mononuclear cell 
(PBMc) isolation and Phenotyping by Flow 
cytometric analysis
Peripheral blood mononuclear cells were prepared by density 
gradient centrifugation with Histopaque1077 (Sigma-Aldrich). 
Briefly, 20  ml of whole blood was layered onto 15  ml of 
Histopaque1077, the samples were centrifuged at 500 ×  g for 
30  min, and PBMC layers were collected and counted with a 
hemocytometer. An aliquot (1 × 106 cells) of PBMCs from each 
sample was stored at −80°C in heat-inactivated human AB 
serum (Sigma-Aldrich) containing 10% dimethyl sulfoxide. The 
frequencies of different cell populations were analyzed in these 
previously frozen samples by the use of multiparameter flow 
cytometry. Surface staining with anti-human CD4–allophyco-
cyanin (APC), anti-CD8–APC, anti-CD45RA–fluorescein, and 
anti-CD27–R-phycoerythrin-Cy5 antibodies was carried out in 
flow cytometry staining buffer for 30 min at 4°C (all reagents from 
eBioscience). The viability of each sample was determined by the 
use of forward-scattered and side-scattered light parameters for 
size exclusion, and an unstained control sample and appropriate 
isotype controls were used for setting gates. Single stains with 
anti-human CD3 antibodies coupled to different fluorophores 
were used to assess compensation settings prior to acquisition, 
and to establish a compensation matrix for data analysis. At least 
10,000 cells were analyzed on a FACS-calibur™ flow cytometer 
(Becton Dickinson) by the use of FlowJo software (Tree Star). T 
lymphocyte subsets were identified by CD4 and CD8 expression 
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analysis. Subsequent multiparameter quadrant analysis on these 
T lymphocyte populations further characterized phenotypes 
using CD45RA and CD27 (19). Thus, naive cells were defined 
as CD45RA+ CD27+, central memory (CM) cells as CD45RA− 
CD27+, effector memory (EM) cells as CD45RA− CD27−, and 
EM RA positive (EMRA) cells as CD45RA+ CD27−.
generation of PPD–hsa conjugate
A solution of HSA (Sigma-Aldrich) at 10 mg/ml (150 µM) and 
15 mM PPD (Sigma-Aldrich; ×100 molar excess) was dissolved 
in 10 ml of phosphate-buffered saline (PBS). The reaction mix-
ture was stirred at room temperature for 48 h, and the solution 
was dialyzed against PBS for a further 72 h, with the PBS being 
changed every 4–12  h. The solution was lyophilized, and the 
conjugate was then stored as a powder at −80°C or dissolved in 
PBS and stored at −20°C for use in in vitro assays. The degree of 
HSA modification by PPD was measured by hapten–protein sub-
stitution analysis. Briefly, 200 µl of PPD–HSA or HSA at 10 mg/
ml in PBS and PBS alone were incubated at room temperature 
for 20 min with 5 µl of 0.03 M 2,4,6-trinitrobenzenesulfonic acid 
(Sigma-Aldrich). The optical density was measured at 405 nm on 
a Biotek reader.
[3h]Thymidine Proliferation assay
The culture medium consisted of RPMI-1640 supplemented with 
l-glutamine (2  mM), 10% heat-inactivated human AB serum, 
HEPES (1%), penicillin (100 U/ml), and streptomycin (100 µg/
ml) (all from Sigma-Aldrich). PBMCs were cultured in 96-well 
flat-bottomed plates, at 1 × 105 cells/well, in 200 µl of complete 
medium, in the presence of PPD–HSA (0.01–100 µg/ml) or HSA 
only (0.01–100 µg/ml) for 6 days. Each well was pulsed at 120 h 
with 22.2 μBq of [3H]thymidine; the cells were then harvested 
and processed for β-scintillation counting 16  h later. A posi-
tive proliferative response was defined as one that resulted in a 
proliferation index of ≥2.5 as compared with control (medium 
only) cells. Stimulation with irrelevant antigen controls resulted 
in proliferation indices of <2.5.
Tcr sequencing
RNA was isolated from 5 ×  106 ex vivo PBMCs derived from 
PPD-sensitized donors using an RNeasy MiniKit (Qiagen). The 
remaining PBMCs were cultured for 6 days in 96-well flat-bot-
tomed plates, at 1 × 105 cells/well, in 200 µl of complete medium, 
in the presence of 100  µg/ml PPD–HSA, 100  µg/ml HSA, or 
medium only. Cells from six wells per condition were pooled, 
and RNA was isolated using the RNeasy MicroKit (Qiagen). Up to 
500 ng of RNA were DNase-treated to remove residual genomic 
DNA using RQ1 DNase (Promega). cDNA was generated using 
two TCR gene-specific primers (αRC2 and βRC2), and following 
the manufacturer’s instructions for SuperScript III (Invitrogen) in 
final volume of 30 µl with the exception that RNasin (Promega) 
was used instead of RNaseOUT. cDNA was purified and concen-
trated using MinElute columns (Qiagen). The following ligation 
reaction was used as part of a 5′-RACE strategy to label every 
cDNA molecule uniquely with a barcode (or unique molecular 
identifier) containing 12 random nucleotides: 10 µl cDNA, 1× T4 
RNA ligase buffer (NEB), 1.5 µM BSA (NEB), 1 mM hexammine 
cobalt chloride, 0.33  mM ATP (NEB), 0.33  µM ligation oligo 
(6N_I8.1_6N_I8.1_SP2, Sigma), 10 µl of 50% PEG8000 (NEB), 
and 20 units T4 RNA ligase 1 (NEB) in a total reaction volume of 
30 µl. Samples were incubated at 16°C for 16 h and the enzyme 
inactivated at 65°C for 10 min. Also, 70 µl of water were added 
before the reaction was purified at a 1:2 bead:sample ratio using 
AMPure XP SPRI beads (Beckman Coulter) according to manu-
facturer’s instructions and eluting in 30–35 µl water. Next, two 
consecutive PCR reactions were performed to amplify the sam-
ples and introduce index sequences to multiplex several samples 
on one sequencing run as well as introduce sequences essential 
for the sequencing reaction. The conditions for PCR 1 were 1× 
HF buffer (NEB), 0.5  µM of αRC1, βRC1.1, βRC1.2, and SP2 
primers, 0.5 mM dNTPs (Life Technologies), and 1 unit Phusion 
polymerase (NEB). The 50 µl reactions were run on a Thermal 
cycler; initial cycle: 98°C, 3  min; cycle 1–4: 98°C, 15  s; 69°C, 
30 s, and 72°C 40 s; final cycle: 72°C, 5 min. The PCR product 
was purified with AMPure beads (ratio 0.8:1 bead:sample) and 
eluted in 30 µl water. The second PCR was performed as a qPCR 
(ABI 7500), so that the reaction could be halted when enough 
material had been amplified. A CT threshold of 0.01 resulted in 
sufficient material for sequencing, and 14–18 cycles of qPCR were 
usually needed to reach that threshold. TCRα and β chains were 
amplified separately. A 25 µl reaction contained 12.4 µl sample, 
1× HF buffer (NEB), Cybrgreen (Life Technologies), 0.25  µM 
dNTPs, Rox (Life Technologies), 0.05 µM of primers SP1-6N-I-
X-αRC1 or SP1-6N-I-X-βRC1.1+1.2, SP1-P5 and P7-LX and 0.5 
units Phusion (NEB). The samples were purified as before, and 
final products were quantified using a Qubit fluorometer (Life 
Technologies) and fractionated on a TapeStation (Agilent). Mixes 
of up to 12 samples were sequenced on an Illumina MiSeq, using 
version 2 chemistry 2x250PE kits.
Sequences were first demultiplexed, according to the two indi-
ces that had been introduced into each sample, using a custom 
Python script. A modified version of Decombinator (16) was then 
used to identify the V and J region used, the number of nucleotide 
deletions from the V and the J gene, the inserted nucleotides, and 
the barcode information. Finally, a custom PCR- and sequencing-
error correction script was used to quantify the number of TCRs 
sequenced. The Python scripts are available at https://github.com/
innate2adaptive/Decombinator. The raw sequence data fastq files 
are available at the NCBI Short Read Archive with accession 
numbers SAMN06270339, SAMN06270340, SAMN06270341, 
SAMN06270342, SAMN06270343, SAMN06270344, 
SAMN06270345, and SAMN06270346.
resUlTs
The proliferative response of peripheral blood T cells from 
a cohort of individuals with ACD (as diagnosed by patch test 
result and clinical history) to PPD was measured in  vitro. In 
preliminary studies we added free PPD to the culture wells, but 
the chemical proved to be cytotoxic at higher concentrations, 
and the proliferative response was therefore difficult to quantify 
reproducibly. Instead, we made conjugates of PPD and HSA and 
measured the response to the chemical conjugate. As described 
FigUre 1 | Proliferation in vitro following challenge with paraphenylenediamine (PPD)–human serum albumin (hsa) conjugates. (a) Median, 
interquartile range, and 95th percentile thymidine incorporation for all samples as a function of in vitro antigen dose. Stars indicate significant difference by one-way 
ANOVA (*p < 0.05; **p < 0.001). (B) Thymidine incorporation using 100 µg/ml PPD–HSA as a function of patient patch test result.
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previously (20), we observed a dose-dependent proliferative 
response to PPD–HSA, with significantly increased [3H]thymi-
dine incorporation at 10 and 100 µg/ml conjugate (Figure 1A). 
Further experiments used 100 µg/ml as this gave the maximum 
proliferation. The proliferation showed a trend to correlation 
with patch test score (Figure 1B) although there was substantial 
variability in the proliferation observed in patients with high 
score, such that the correlation did not reach statistical signifi-
cance with this number of patients.
We looked in further detail at the phenotypic changes 
observed in the proliferation cultures. The flow cytometry 
results on a typical sample with high in  vitro antigen-specific 
proliferation (1 of 12 independent experiments analyzed) is 
shown in Figure  2A, and the accompanying proliferation to 
PPD–HSA and to the HSA control are shown in Figure  2B. 
The CD4 and CD8 cells were analyzed separately and stained 
with a combination of CD27 and CD45RA to define naive, CM, 
EM, and EM CD45RA revertants (EMRA) (19). The in  vitro 
culture contained a smaller proportion of fewer CD8+ naïve 
cells (perhaps because of selective cell death). The addition of 
antigen (PPD–HSA, 100 µg/ml) caused a small shift from CM 
to EM in both CD4+ and CD8+ populations, when compared 
to cells cultured in medium alone. This effect albeit small was 
seen consistently. The mean decrease in CM CD4+ was 9% 
(SEM = 2.5, n = 5), and the corresponding increase in EM CD4+ 
was 9 (SEM = 2.6, n = 5). The mean decrease in CM CD8+ was 
2% (SEM = 1.0, n = 5), and the corresponding increase in EM 
CD4+ was 2% (SEM = 0.8, n = 5). HSA alone caused similar 
phenotypic changes, suggesting some non-specific carrier-
dependent effect. However, thymidine incorporation indicates 
less cell proliferation in response to HSA, suggesting that HSA 
may induce phenotypic maturation with less proliferation than 
PPD–HSA.
Interestingly, we noted that the ex vivo CD4 and CD8 
populations showed a profound depletion in the proportion 
of EM populations in  vivo, compared to the values reported 
previously (19). This observation was consistent among differ-
ent patients and replicates an observation made previously on 
PBMC from patients with allergy to methylisothiazolinone (21). 
Since we did not have access in this study to blood samples taken 
before the patch test, we could not determine whether the obser-
vation related to allergic status or as a response to the exposure 
to PPD in the diagnostic patch test, so this observation was not 
pursued further.
We next examined the TCR repertoire of the T cells cultured 
in vitro. The T cells were collected after culture, pooled to give 
0.5–1 × 106 T cells, and processed for TCRα and TCRβ sequenc-
ing. The pipeline generates a list of distinct TCR sequences for 
each sample, together with an abundance indicating the number 
of times the sequence is found within that sample. The abundance 
of each distinct TCR found in the ex vivo and in the in  vitro 
stimulated samples (HSA or PPD–HSA) was plotted. We find a 
clear expansion of TCRα and β sequences following PPD–HSA 
stimulation that do not expand following HSA stimulation but 
are present at lower frequency in the HSA only as well as in the 
ex vivo sample. For each distinct TCR sequence identified after 
6  days of culture, we then calculated a stimulation index (SI), 
defined as the logarithm (base 2, equivalent to the number of cell 
doublings if cell death is ignored) of the abundance in the in vitro 
culture relative to the abundance in the ex vivo sample. The 
abundance of the TCRs that were absent from the ex vivo sample 
(due to sampling) is estimated as 1 (since abundances of ex vivo 
samples have a mean of 1.3, median of 1, and TCRs observed 
in  vitro after proliferation must have been present at the start 
of the proliferation assay with an abundance of at least 1). The 
SI for cultures with medium alone or in the presence of antigen 
(PPD–HSA, 100 µg/ml) is shown in Figure 3A. The majority of 
TCRs show no change or a slight decrease in frequency following 
in  vitro culture. This is consistent with the overall stability of 
phenotype seen after culture in vitro. However, a small number 
of sequences are found at much higher abundance after culture 
in the presence of antigen. The number of distinct TCRs with 
FigUre 2 | Memory phenotype and thymidine proliferation for patient 91. (a) Flow cytometry showing the four populations of naïve, central memory, EM and 
EMRA as defined by the combination of CD45RA and CD27 expression for CD4 (left) and CD8 (right). The top row shows phenotype of cells directly ex vivo, while 
the lower two rows show the phenotype after in vitro culture with or without antigen as shown. (B) Proliferation (thymidine incorporation) in response to 
paraphenylenediamine (PPD)–human serum albumin (HSA) (filled) or HSA (mean and SD, 4 replicate cultures per point). NT, not tested. *p < 0.05 (Student’s t-test).
FigUre 3 | (a) Stimulation index (SI) distribution for in vitro T cell receptors (TCRs). The SI is calculated as the logarithm (base 2) of the abundance in the in vitro 
culture with medium alone (empty bars) or stimulated with 100 µg/ml paraphenylenediamine (PPD)–human serum albumin (HSA) (filled bars) relative to the 
abundance in the ex vivo sample. The abundance of the TCRs that are absent from the ex vivo sample is estimated as 1 (mean abundance in ex vivo samples is 
1.3). (B) The number of TCRs with a SI > 3 (i.e., more than eightfold expanded in in vitro culture) for cultures in medium, HSA, or PPD–HSA.
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FigUre 4 | The relative T cell receptor (Tcr) abundances in different in vitro cultures. (a) Heat map showing the abundance of each TCR with a 
stimulation index (SI) > 8 in paraphenylenediamine (PPD)–human serum albumin (HSA) cultures, in cultures with medium alone, HSA, or in the ex vivo (PB) sample. 
Each row of the heat map is a distinct TCR gene sequence, colored according to its abundance. The TCRs are ranked in order of their abundance in the PPD–HSA 
cultures. (B) The relative frequency of TCR in PPD–HSA (x axis) cultures versus HSA alone (y axis). Each dot represents a distinct TCR, and the color represents 
frequency in the PB sample. (c) Histograms of the abundances in all four repertoires of all TCRs with an SI > 8 in PPD–HSA cultures and an SI > 1 in HSA cultures.
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an SI greater than 3 (eightfold increase or three divisions) in 
cultures with medium alone, PPD–HSA, or HSA alone is shown 
in Figure 3B. The qualitative pattern observed is similar to the 
pattern of thymidine incorporation shown in Figure  2B. The 
approximately 800 expanded TCRα and TCRβ sequences are 
equivalent to about 0.8% of the total number of TCRs detected, 
reflecting the specificity of the proliferative response observed.
We next compared the abundance (Figure  4A) or the 
frequency (Figure  4B) of the TCRs that were expanded in 
the PPD–HSA cultures, in the HSA only, medium only (in 
Figure  4A only), or ex vivo repertoire. In general, the TCRs 
expanded in PPD–HSA were not observed at high abundance 
in the other cultures. However, in many cases, the sequence was 
simply not observed in the corresponding other cultures. This 
could have been due to differential amplification or sampling 
(i.e., the relevant precursor was not present in the culture at the 
start). In order to look more carefully at specificity, we plotted 
the abundance of all the clones shown in Figure 4A, which were 
also present at least once in the HSA culture (Figure 4C). The 
abundance of the TCRs varied quite broadly, with some TCRs 
showing abundances of >500 after culture in PPD–HSA. In 
contrast, abundances in the HSA cultures were always less than 
FigUre 5 | The abundance distribution of all complementarity-determining region (cDr)3 in the ex vivo sample (empty bars) compared to the 
abundance of T cell receptors (Tcrs) in the ex vivo samples that are expanded following paraphenylenediamine (PPD)–human serum albumin (hsa) 
stimulation in vitro (the PPD–hsa expanded) [stimulation index (si) > 3] Tcrs (filled bars). Asterisk shows those values for which the proportion differs 
significantly (p < 0.01) using the z-test for proportions.
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10, suggesting that the expansion observed was specific to the 
presence of the PPD hapten.
We examined whether the TCRs that had expanded in the 
presence of PPD–HSA (SI > 3) represented a population, which 
had been pre-expanded in vivo. Figure 5 shows the abundance 
of the PPD–HSA expanded TCRs in the ex vivo pre-expansion 
sample. The distribution is compared to the overall abundance 
distribution in the ex vivo sample from the same donor. The 
histogram for the expanded set of TCRs shows a clear shift toward 
higher abundance, with >20% of the expanded TCRs having an 
abundance of >2 in the PBMC sample. Thus the set of TCRs, 
which expand in vitro are already present at higher frequencies 
than average in  vivo, consistent with being derived from an 
allergen-induced memory T cell response.
Several previous studies have reported that antigen-specific 
responses often favor specific V genes [e.g., Ref. (22)]. We 
therefore compared the frequency of each V and J α and β 
gene in the PPD–HSA expanded TCRs with their frequency in 
the ex vivo pre-culture sample (Figure 6). Since the size of the 
set of expanded TCRs is rather small (in the order of 800) we 
selected 100 repeated samples from the ex vivo repertoire to 
estimate sampling heterogeneity. We then plotted the frequency 
in the antigen-expanded sample with the frequency in blood. The 
majority of genes fell in or near the diagonal, indicating a similar 
frequency in PBMC and in antigen cultures. However, for both V 
and J genes, one or more gene showed substantial changes after 
culture. TRAV29/DV5, for example, was present at 10 times its 
frequency in the matched PBMC sample (Figure 6). Thus in vitro 
culture with PPD–HSA conjugate drives selective expansion of 
TCRs with skewed V and J gene usage.
The TCR region with the greatest contact with antigen/
MHC complex is the CDR3 loop. The relationship between two 
CDR3 sequences can be captured by the Levenshtein distance, 
the number of changes (i.e., substitution, deletion, and addition) 
required to transform one CDR3 into the other. The amino acid 
sequences of the 800 expanded TCRs were clustered according to 
their Levenshtein distance matrix (Figure 7A). The sequences fall 
into a number of families of closely related sequences. A multi-
sequence alignment of the subtree containing the most abundant 
TCRβ CDR3 member is illustrated as an example (Figure 7B). 
The sequences within a family show a high degree of conservation, 
especially toward the N terminal part of the sequence. However, 
the overall average Levenshtein distance between all expanded 
CDRs (α = 9.53, β = 8.61) is only slightly smaller than between 
a random sample of ex vivo (pre-expanded) TCRS (α =  9.81, 
β = 9.47). PPD–HSA exposure therefore drives the expansion of 
families of TCRs, which are strongly conserved within a family 
but weakly related or unrelated between families.
DiscUssiOn
Paraphenylenediamine is widely used as a hair dye (17) and as a 
component of black henna tattoos (23), and the overall prevalence 
of PPD contact allergy was 0.8% in a recent study of European 
populations (18). The immune response to PPD, therefore, serves 
as a good model with which to study the immune response to 
contact allergens and to understand better the nature of allergen 
recognition. In this study we analyzed the T cell response to PPD 
at the level of TCR repertoire, highlighting the breadth of TCRs 
associated with antigen-induced proliferation.
The response to PPD, and to contact allergens in general, is 
believed to reflect a T cell response, comprising both CD4+ and 
CD8+ T cells (1). We therefore measured T cell in vitro prolifera-
tive responses in PBMC from a cohort of individuals clinically 
diagnosed as PPD-allergic and who were shown to be patch test 
positive. A chemical conjugate of PPD with HSA was used as it is 
less cytotoxic than free PPD and has previously been character-
ized in detail (20, 24). We first confirmed previous reports that 
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peripheral blood T cells show a dose-dependent antigen-specific 
response to PPD–HSA, as measured by [3H]thymidine incorpo-
ration. In vitro culture was associated with a selective loss of naïve 
T cells and a small shift from CM to EM in cultures exposed to 
antigen.
Interestingly, we noted that the starting PBMC population 
from the PPD-allergic individuals appeared to be depleted of EM 
cells, compared to the values reported previously for healthy vol-
unteers (19). This might reflect recruitment of effector cells from 
blood to the skin either due to the patch test carried out 4 days 
prior to venepuncture or to the allergic condition itself. A similar 
observation was recently reported for another skin sensitizer, 
methylisothiazolinone (21). Further longitudinal studies will 
be required to establish the cause of this relative paucity of EM 
cells in the peripheral blood and its possible impact on responses 
measured in vitro.
Our TCRseq protocol incorporates unique molecular identi-
fiers, which allow us to count accurately the number of TCR RNA 
molecules present in a sample. The relationship between RNA count 
and cell count depends on the number of TCR RNA molecules 
per cell. Although we cannot rule out some changes in RNA levels 
during different phases of T cell activation, previous studies do 
not suggest substantial changes (25, 26) and would not contribute 
significantly to the large changes in abundance we observe.
An SI of approximately 9, equivalent to a 500-fold increase 
in abundance, is consistent with a culture period of 6 days, and 
T cell replication times of around 24 h for the first generation, 
and 16–18  h for subsequent generations (27). We do not have 
dynamic information on T cell numbers during the culture, but 
since thymidine incorporation is a function of those cells still in S 
phase during the last day of culture, these results suggest that the 
observed proliferation can be attributed to a few thousand cells 
derived from only 2–4 precursors per 100,000 T cells. These TCRs 
are not expanded in cultures without PPD–HSA, suggesting they 
represent antigen-specific responses to the PPD conjugate.
Together with a very small number of T cells that continue to 
proliferate throughout the culture, we also observed many more 
cells (approximately 0.8% of total), which increase in abundance 
by a smaller amount. We cannot determine whether these cells 
represent PPD-specific cells of lower affinity, which respond less 
robustly to antigen, or perhaps include bystander cells activated 
in  vitro as a result of antigen-presenting cell activation and 
cytokine secretion.
The sequences of the TCRs expanded in vitro show hallmarks 
of an antigen-specific response. They exhibit strong skewing of 
both V and J gene usage (28–30), and they consist of families of 
TCRs with conserved α and β CDR3s. Nevertheless, the in vitro 
expanded TCRs show only slightly greater similarity to each other 
FigUre 6 | V and J gene usage in paraphenylenediamine–human serum albumin expanded T cell receptors (Tcrs) compared to random Tcrs. For 
each V or J gene, the abundance in the expanded TCR set illustrated in Figure 4a is shown along the y axis, and the abundance (mean plus 2 SDs) in 100 
equal-sized random samples of TCRs drawn from the ex vivo repertoires is shown along the x axis. The full names of those genes, which differ significantly from the 
diagonal (i.e., are over- or underrepresented in the expanded set) are shown.
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FigUre 7 | The sequence relationship between the complementarity-determining region (cDr3)β sequences of the T cell receptors (Tcrs), which 
are expanded [stimulation index (si) > 3] after culture in the presence of paraphenylenediamine–human serum albumin. (a) Unrooted tree of all 
expanded TCRβ CDR3 clustered according to Levenshtein distances (Ward agglomerative clustering). (B) Multiple sequence alignment and sequence logo of the 
subtree of (a) containing the most expanded CDR3β sequence.
than they do to a random selection of CDR3s from the in vivo 
repertoire, and the clones showing a high SI are found in several 
different and quite distinct families of CDR3 sequences.
It is instructive to compare the results observed here with 
those of an extended series of studies on T cell responses to 
another strong contact sensitizer, trinitrophenyl (TNP) sulfonic 
acid [reviewed in Ref. (31)]. Although carried out prior to the era 
of high throughput sequencing, and in an experimental mouse 
model, these studies reported remarkably similar qualitative fea-
tures of the contact sensitizer-specific responses. In particular, the 
TNP response was associated with a high frequency of hapten-
specific T cells (32), was associated with strong preferential usage 
of certain V and J regions in both alpha and beta chain (33, 34), 
but was nevertheless very polyclonal involving a wide variety of 
different TCR sequences (9, 35). These features may therefore 
represent common features of the sensitizer-specific repertoire 
in both mouse and man.
The results of our study are consistent with a model in which 
PPD–HSA conjugate stimulates a broad diversity of TCRs, and 
with a wide range of stimulation strengths, which manifest as dif-
ferent degrees of in vitro expansion. The reasons for the breadth 
of response observed remain to be defined. Although PPD has 
been shown to react principally with a single free cysteine in HSA 
(20), smaller amounts of alternative conjugate products may also 
be present, giving rise to a variety of hapten/protein conjugate 
peptides. Alternatively, a single PPD–HSA-derived peptide may 
be processed and presented by APC in a variety of ways and 
recognized by a variety of T cells.
The study begins to characterize the magnitude and breadth of 
the T cell response to a well-characterized strong skin sensitizer, 
PPD (36). Further investigations are in progress to separate the 
contribution of CD4 and CD8 cells and to define the antigen 
specificity of the responding cells in more detail. The parameters 
learnt from such studies will help achieve a better understanding 
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